
Differentiating Oral DMTs to Optimize Treatment Individualization with Drs. Stephen Krieger and Patricia K. Coyle
12/7/2022
0:00
15:56
In this podcast, expert clinicians will revisit an important topic from MS Forum® VIII, the use of current and emerging oral therapies for MS, including the Burton's tyrosine kinase (BTK) inhibitors.
More episodes from "MedEdTalks - Neurology"



Don't miss an episode of “MedEdTalks - Neurology” and subscribe to it in the GetPodcast app.








